During the past decade, Hospital General Universitario Santa Lucía conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario Santa Lucía" #1 sponsor was "PETHEMA Foundation" with 5 trials, followed by "Celgene" with 4 trials sponsored, "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia" with 2 trials sponsored, "Grupo de Investigación Clínica en Oncología Radioterapia" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Santa Lucía" #1 collaborator was "Dynamic Science S.L." with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Adknoma" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Santa Lucía" are "Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials), "Leukemia, Myeloid, Acute" (2 trials), "Newly Diagnosed Multiple Myeloma" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Hospital General Universitario Santa Lucía" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario Santa Lucía" are "Drug" (17 trials), "Other" (6 trials), "Radiation" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (3 trials), "Bortezomib" (2 trials), "Irradiation" (2 trials), "Lenalidomide" (2 trials) and "Radiotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario Santa Lucía" are 33 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Universitario Santa Lucía". 1 are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hospital General Universitario Santa Lucía, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario Santa Lucía, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".